SOMA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Soma, and when can generic versions of Soma launch?
Soma is a drug marketed by Mylan Speciality Lp, Meda Pharms, and Ipsen Pharma. and is included in four NDAs.
The generic ingredient in SOMA is lanreotide acetate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lanreotide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Soma
A generic version of SOMA was approved as lanreotide acetate by INVAGEN PHARMS on December 17th, 2021.
Summary for SOMA
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Patent Applications: | 3,910 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SOMA |
What excipients (inactive ingredients) are in SOMA? | SOMA excipients list |
DailyMed Link: | SOMA at DailyMed |
Pharmacology for SOMA
Drug Class | Muscle Relaxant |
Physiological Effect | Centrally-mediated Muscle Relaxation |
Anatomical Therapeutic Chemical (ATC) Classes for SOMA
US Patents and Regulatory Information for SOMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | SOMA | carisoprodol | CAPSULE;ORAL | 011792-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipsen Pharma | SOMATULINE DEPOT | lanreotide acetate | SOLUTION;SUBCUTANEOUS | 022074-002 | Aug 30, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meda Pharms | SOMA COMPOUND | aspirin; carisoprodol | TABLET;ORAL | 012365-005 | Jul 11, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipsen Pharma | SOMATULINE DEPOT | lanreotide acetate | SOLUTION;SUBCUTANEOUS | 022074-003 | Aug 30, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Speciality Lp | SOMA | carisoprodol | TABLET;ORAL | 011792-004 | Sep 13, 2007 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |